← All trials
NCT05759078
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 22, 2022
- Primary completion
- Jun 14, 2026
- Completion date
- Jun 14, 2026
- First posted
- Mar 8, 2023
- Last posted
- Sep 21, 2023
- Enrollment
- 2000
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Wroclaw Medical UniversityLead sponsor
- Wroclaw Medical UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.